In fact, according to ChIP sequencing of multiple hematopoietic cell lines, promoter sites of GNB2 were remarkably identified as binding regions of tri-methylated histone H3K4, which serves a major role of oncogenic potential in MLL-associated leukemia [10]. The gene discussed is KMT2A; the disease is leukemia.